Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Agranulocytosis

Schizophrenia

Treatments

Other: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT06610500

IRBN682023/CHUSTE

Details and patient eligibility

About

Clozapine is a drug that requires regular and diligent hematological monitoring throughout its use. This follow-up is, in France, framed by a compulsory paper format of the blood count follow-up notebook for each patient. Due to the multiplicity of the different modes of transmission of the different documents necessary for compliance with the regulations for the prescription, dispensing and administration of clozapine, we decided to carry out a current inventory in the department of Loire with respect for the latter. The main objective of this study is to assess the rate of non-compliance in circuits of prescription, dispensing and administration of clozapine by sending a questionnaire on habits of prescriptions, dispensing and administration of health professionals (psychiatrists, pharmacists), and by sending a questionnaire to the patients treated by clozapine.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Population 1: all patients stabilized of Medical-Psychological Center (CMP) of St-Etienne treated with clozapine
Population 2 : all psychiatrists of the Loire department
Population 2 : all pharmacists of the Loire department

Exclusion criteria